Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Deutsche Medizinische Wochenschrift (1946)
|
August 27, 2021
[A decade of checkpoint inhibitors: current standard of care and future trends]
Anna Reischer, Stephan Kruger, Michael von Bergwelt-Baildon
Cells
|
May 21, 2020
M2 Macrophages Infiltrating Epithelial Ovarian Cancer Express MDR1: A Feature That May Account for the Poor Prognosis
Susann Badmann, Sabine Heublein, Doris Mayr, et al.
Journal of Hematology & Oncology
|
September 28, 2021
SIRPα-αCD123 fusion antibodies targeting CD123 in conjunction with CD47 blockade enhance the clearance of AML-initiating cells
Siret Tahk, Binje Vick, Björn Hiller, et al.
Theranostics
|
January 7, 2020
Therapeutic management of neuro-oncologic patients - potential relevance of CSF liquid biopsy
Louisa von Baumgarten, Jörg Kumbrink, Andreas Jung, et al.
Scientific Reports
|
December 8, 2025
Real-world analysis of immune checkpoint inhibitor efficacy and response predictors in patients treated at the CCCMunich<sup>LMU</sup> outpatient clinic
Klara Dorman, Kilian Breitenwieser, Laura Fischer, et al.
Cancer Immunology, Immunotherapy : CII
|
May 22, 2025
Targeted CD47 checkpoint blockade using a mesothelin-directed antibody construct for enhanced solid tumor-specific immunotherapy
Anna Reischer, Alexandra Leutbecher, Björn Hiller, et al.
Plos Pathogens
|
October 6, 2021
Impaired function and delayed regeneration of dendritic cells in COVID-19
Elena Winheim, Linus Rinke, Konstantin Lutz, et al.
Nature Communications
|
September 23, 2022
Accumulation of mutations in antibody and CD8 T cell epitopes in a B cell depleted lymphoma patient with chronic SARS-CoV-2 infection
Elham Khatamzas, Markus H Antwerpen, Alexandra Rehn, et al.
Hemasphere
|
July 8, 2021
COVID-19 in Patients Receiving CD20-depleting Immunochemotherapy for B-cell Lymphoma
Erik Gaitzsch, Verena Passerini, Elham Khatamzas, et al.
Nature Biomedical Engineering
|
June 4, 2021
T cells armed with C-X-C chemokine receptor type 6 enhance adoptive cell therapy for pancreatic tumours
Stefanie Lesch, Viktoria Blumenberg, Stefan Stoiber, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Deutsche Medizinische Wochenschrift (1946)
|
August 27, 2021
[A decade of checkpoint inhibitors: current standard of care and future trends]
Anna Reischer, Stephan Kruger, Michael von Bergwelt-Baildon
Cells
|
May 21, 2020
M2 Macrophages Infiltrating Epithelial Ovarian Cancer Express MDR1: A Feature That May Account for the Poor Prognosis
Susann Badmann, Sabine Heublein, Doris Mayr, et al.
Journal of Hematology & Oncology
|
September 28, 2021
SIRPα-αCD123 fusion antibodies targeting CD123 in conjunction with CD47 blockade enhance the clearance of AML-initiating cells
Siret Tahk, Binje Vick, Björn Hiller, et al.
Theranostics
|
January 7, 2020
Therapeutic management of neuro-oncologic patients - potential relevance of CSF liquid biopsy
Louisa von Baumgarten, Jörg Kumbrink, Andreas Jung, et al.
Scientific Reports
|
December 8, 2025
Real-world analysis of immune checkpoint inhibitor efficacy and response predictors in patients treated at the CCCMunich<sup>LMU</sup> outpatient clinic
Klara Dorman, Kilian Breitenwieser, Laura Fischer, et al.
Cancer Immunology, Immunotherapy : CII
|
May 22, 2025
Targeted CD47 checkpoint blockade using a mesothelin-directed antibody construct for enhanced solid tumor-specific immunotherapy
Anna Reischer, Alexandra Leutbecher, Björn Hiller, et al.
Plos Pathogens
|
October 6, 2021
Impaired function and delayed regeneration of dendritic cells in COVID-19
Elena Winheim, Linus Rinke, Konstantin Lutz, et al.
Nature Communications
|
September 23, 2022
Accumulation of mutations in antibody and CD8 T cell epitopes in a B cell depleted lymphoma patient with chronic SARS-CoV-2 infection
Elham Khatamzas, Markus H Antwerpen, Alexandra Rehn, et al.
Hemasphere
|
July 8, 2021
COVID-19 in Patients Receiving CD20-depleting Immunochemotherapy for B-cell Lymphoma
Erik Gaitzsch, Verena Passerini, Elham Khatamzas, et al.
Nature Biomedical Engineering
|
June 4, 2021
T cells armed with C-X-C chemokine receptor type 6 enhance adoptive cell therapy for pancreatic tumours
Stefanie Lesch, Viktoria Blumenberg, Stefan Stoiber, et al.
Page
of 1